Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: axial who wrote (12155)	2/26/2003 12:44:45 AM
From: russet	Read Replies (1) \| Respond to of 14101

As those who have studied the matter are aware, you are correct about JnJ's early efforts with DMSO. As you may (or may not) know there are actually two patents, the second being a CIP (Continuation-In-Part) of the first patent. However, there is a Terminal Disclaimer on the first patent. In my opinion, there is no patent on DMSO based delivery systems possible,...it is in the public domain. Most universities have a patent person who could give you an opinion on this matter. Look them up. The Pennsaid delivery system is patentable,...it is three ingredients plus the NSAID and water. I can think of several ingredients that could serve as replacements for the ingredients other than DMSO and water, I my bet is DMX could not stop them from being commercialized with the current patent,...nobody could. J&J can probably think of many more. You have said your bit, I have said mine,..we will see how things come to be. Good luck with your investments,..including this one. I have enjoyed our,..discussions.